UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$495M |
| 2 |
Microsoft
MSFT
|
+$480M |
| 3 |
Global Payments
GPN
|
+$400M |
| 4 |
Mastercard
MA
|
+$274M |
| 5 |
Comcast
CMCSA
|
+$254M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TSS
Total System Services, Inc.
TSS
|
+$225M |
| 2 |
WP
Worldpay, Inc.
WP
|
+$190M |
| 3 |
Apple
AAPL
|
+$167M |
| 4 |
RHT
Red Hat Inc
RHT
|
+$166M |
| 5 |
APC
Anadarko Petroleum
APC
|
+$108M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.77% |
| 2 | Financials | 14.07% |
| 3 | Healthcare | 13.13% |
| 4 | Consumer Discretionary | 12.1% |
| 5 | Communication Services | 8.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1301
iShares Broad USD Investment Grade Corporate Bond ETF
USIG
$17.3B
| $3.64M | ﹤0.01% |
62,448
-1,153
| -2% | -$66.5K |
|
1302
ICICI Bank
IBN
$108B
| $3.63M | ﹤0.01% |
298,007
-22,450
| -7% | -$263K |
|
|
CMD
1303
DELISTED
Cantel Medical Corporation
CMD
| $3.62M | ﹤0.01% |
48,381
+1,887
| +4% | +$160K |
|
|
TMHC
1304
DELISTED
Taylor Morrison
TMHC
| $3.61M | ﹤0.01% |
139,333
+1,162
| +0.8% | +$26.8K |
|
1305
ICU Medical
ICUI
$4.61B
| $3.6M | ﹤0.01% |
22,587
-16,326
| -42% | -$3.25M |
|
1306
Louisiana-Pacific
LPX
$5.49B
| $3.6M | ﹤0.01% |
146,364
+2,099
| +1% | +$51.7K |
|
1307
Adient
ADNT
$1.5B
| $3.59M | ﹤0.01% |
156,277
-54,180
| -26% | -$1.24M |
|
|
UNVR
1308
DELISTED
Univar Solutions Inc.
UNVR
| $3.57M | ﹤0.01% |
172,153
-14,442
| -8% | -$299K |
|
1309
Neogen
NEOG
$2.5B
| $3.57M | ﹤0.01% |
104,898
+14,420
| +16% | +$499K |
|
1310
Tenet Healthcare
THC
$21.1B
| $3.57M | ﹤0.01% |
161,473
-2,654
| -2% | -$56.5K |
|
1311
Texas Roadhouse
TXRH
$13.7B
| $3.57M | ﹤0.01% |
67,920
+12,553
| +23% | +$666K |
|
|
UHT
1312
Universal Health Realty Income Trust
UHT
$594M
| $3.52M | ﹤0.01% |
34,272
+4,032
| +13% | +$380K |
|
1313
Viavi Solutions
VIAV
$9.66B
| $3.52M | ﹤0.01% |
251,511
+41,202
| +20% | +$586K |
|
|
SAFM
1314
DELISTED
Sanderson Farms Inc
SAFM
| $3.51M | ﹤0.01% |
23,193
+1,952
| +9% | +$278K |
|
1315
Texas Pacific Land
TPL
$23.5B
| $3.5M | ﹤0.01% |
48,528
+8,235
| +20% | +$642K |
|
1316
Fulton Financial
FULT
$4.64B
| $3.5M | ﹤0.01% |
216,027
+17,732
| +9% | +$289K |
|
1317
Sinclair Inc
SBGI
$1.03B
| $3.48M | ﹤0.01% |
81,509
+2,035
| +3% | +$98.5K |
|
1318
AnaptysBio
ANAB
$1.68B
| $3.48M | ﹤0.01% |
99,518
-2,516
| -2% | -$120K |
|
1319
Avis
CAR
$5.02B
| $3.48M | ﹤0.01% |
123,067
-5,633
| -4% | -$173K |
|
|
NUVA
1320
DELISTED
NuVasive, Inc.
NUVA
| $3.48M | ﹤0.01% |
54,843
+8,781
| +19% | +$549K |
|
1321
Cabot Corp
CBT
$4.52B
| $3.46M | ﹤0.01% |
76,338
-1,737
| -2% | -$74.9K |
|
1322
Element Solutions
ESI
$9.23B
| $3.46M | ﹤0.01% |
339,674
+11,209
| +3% | +$110K |
|
1323
MGE Energy Inc
MGEE
$3.08B
| $3.46M | ﹤0.01% |
43,279
+6,288
| +17% | +$470K |
|
1324
Genworth Financial
GNW
$3.71B
| $3.45M | ﹤0.01% |
782,958
-47,830
| -6% | -$199K |
|
|
VRN
1325
DELISTED
Veren
VRN
| $3.44M | ﹤0.01% |
805,417
+12,287
| +2% | +$42.6K |
|
Similar funds
UBS AM's Q3 2019 Portfolio in Review
As of Q3 2019, UBS AM held 2,935 positions worth $148B, up 5.8% from $140B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
UBS AM deployed $6.46B of net new capital in Q3 2019, opening 79 new positions and adding to 1,853 existing holdings. Its largest new stake was 10x Genomics: 184,683 shares worth $9.31M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Apple, an estimated $167M trimmed.
- UBS AM's largest Q3 2019 buy was 10x Genomics: 184,683 shares worth $9.31M.
- UBS AM added most to Alibaba in Q3 2019, an estimated $495M increase.
- UBS AM's biggest Q3 2019 reduction was Apple, cutting an estimated $167M.
- UBS AM fully exited Total System Services, Inc. in Q3 2019, selling an estimated $225M.
- UBS AM's ten largest holdings make up 19% of its $148B portfolio in Q3 2019.
- UBS AM opened 79 new positions and closed 50 in Q3 2019.
- UBS AM's portfolio value rose 5.8% quarter-over-quarter to $148B.
Based on UBS AM's 13F filing for Q3 2019, filed 14 Nov 2019.